US Supreme Court strikes Myriad blow

13-06-2013

US Supreme Court strikes Myriad blow

The US Supreme Court has ruled that isolated human DNA is not patent eligible and has struck down patents owned by biotech company Myriad, ending a long-running and controversial case.


US Supreme Court, Myriad, BRCA1, BRCA2

LSIPR